|1.||Rodrigues, V M: 2 articles (07/2003 - 06/2001)|
|2.||Giglio, J R: 2 articles (07/2003 - 06/2001)|
|3.||Teixeira, David Nascimento Silva: 1 article (12/2008)|
|4.||Homsi-Brandeburgo, Maria Inês: 1 article (12/2008)|
|5.||Silva, Deise Aparecida Oliveira: 1 article (12/2008)|
|6.||Rodrigues, Veridiana Melo: 1 article (12/2008)|
|7.||Hamaguchi, Amélia: 1 article (12/2008)|
|8.||Júnior, Robson J Oliveira: 1 article (12/2008)|
|9.||Bastos, Luciana Machado: 1 article (12/2008)|
|10.||Vieira, Carlos Ueira: 1 article (12/2008)|
07/01/2003 - "The pulmonary hemorrhage induced by neuwiedase when injected intravenously with 0.6 LD(50) was completely inhibited when this toxin was incubated with the extract at a ratio of 1:10 (w/w, toxin/extract). "
06/01/2001 - "In addition, large doses of neuwiedase may contribute to pulmonary bleeding"
12/01/2008 - "gondii infection cause considerable side effects, particularly in immunocompromised individuals and pregnant women, the results of neuwiedase treatment described herein could be taken into account for the development of new synthetic therapeutic agents, mainly due to the capacity of this enzyme to degrade extracellular matrix components, such as laminin, fibronectin and type I collagen, which is important to interfere in T. "
06/01/2001 - "It is concluded that neuwiedase, despite its lack of hemorrhagic effect when injected in the gastrocnemius muscle, contributes to local tissue damage by inducing edema, inflammatory infiltrate and mild myotoxicity, and by degrading extracellular matrix components. "
06/01/2001 - "Moreover, a conspicuous edema developed in the foot pad after subcutaneous injection of neuwiedase. "
|1.||Collagen Type I (Type I Collagen)